Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
…, N Gamalath, D Ekanayake, J Jayamali… - Immunity …, 2022 - Wiley Online Library
Background To determine the kinetics and persistence of immune responses following the
Sinopharm/BBIBP‐CorV, we investigated immune responses in a cohort of Sri Lankan …
Sinopharm/BBIBP‐CorV, we investigated immune responses in a cohort of Sri Lankan …
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals
…, N Gamalath, D Ekanayake, J Jayamali… - MedRxiv, 2021 - medrxiv.org
Background To determine the kinetics and persistence of immune responses following the
Sinopharm/BBIBP-CorV, we investigated immune responses in a cohort of Sri Lankan …
Sinopharm/BBIBP-CorV, we investigated immune responses in a cohort of Sri Lankan …
Comparison of the immunogenicity of five COVID‐19 vaccines in Sri Lanka
…, H Kuruppu, G Somathilake, J Jayamali… - …, 2022 - Wiley Online Library
To determine the antibody responses elicited by different vaccines against SARS‐CoV‐2, we
compared antibody responses in individuals 3 months post‐vaccination in those who had …
compared antibody responses in individuals 3 months post‐vaccination in those who had …
Immune responses to Sinopharm/BBIBP‐CorV in individuals in Sri Lanka
…, N Gamalath, D Ekanayake, J Jayamali… - …, 2022 - Wiley Online Library
As there are limited data of the immunogenicity of the Sinopharm/BBIBP‐CorV in different
populations, antibody responses against different SARS‐CoV‐2 variants of concern and T cell …
populations, antibody responses against different SARS‐CoV‐2 variants of concern and T cell …
Identification of differences in the magnitude and specificity of SARS-CoV-2 nucleocapsid antibody responses in naturally infected and vaccinated individuals
…, IS Aberathna, T Nimasha, J Jayamali… - Clinical and …, 2024 - academic.oup.com
As there are limited data on B-cell epitopes for the nucleocapsid protein in SARS-CoV-2, we
sought to identify the immunodominant regions within the N protein, recognized by patients …
sought to identify the immunodominant regions within the N protein, recognized by patients …
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
…, N Gamalath, D Ekanayake, J Jayamali… - Immunity …, 2022 - Wiley Online Library
Background To understand the kinetics of immune responses with different dosing gaps of
the AZD1222 vaccine, we compared antibody and T cell responses in two cohorts with two …
the AZD1222 vaccine, we compared antibody and T cell responses in two cohorts with two …
[HTML][HTML] Comparison of the kinetics and magnitude of antibody responses to different SARS-CoV-2 proteins in Sinopharm/BBIBP-CorV vaccinees following the …
…, T Nimasha, T Ranasinghe, J Jayamali… - PLoS …, 2022 - journals.plos.org
The kinetics and magnitude of antibody responses to different proteins of the SARS-CoV-2
virus in Sinopharm/BBIBP-CorV vaccinees has not been previously studied. Therefore, we …
virus in Sinopharm/BBIBP-CorV vaccinees has not been previously studied. Therefore, we …
Immune responses to a single dose of the AZD1222/Covishield vaccine at 16 weeks in individuals in Sri Lanka
…, S Dayarathna, D Ekanayake, J Jayamali… - The Journal of …, 2021 - journals.aai.org
Due to limited access to vaccines, many countries have only administered a single dose of
the AZD1222, whereas the dosage intervals have increased≥ 4 wk. We sought to investigate …
the AZD1222, whereas the dosage intervals have increased≥ 4 wk. We sought to investigate …
The burden of dengue in children and risk factors of transmission in nine districts in Sri Lanka
…, P Pushpakumara, L Gomes, J Jayamali… - Journal of Medical …, 2024 - Wiley Online Library
We sought to understand the differences in age‐stratified seroprevalence rates in different
regions in Sri Lanka to plan dengue vaccination programs, especially as the WHO has given …
regions in Sri Lanka to plan dengue vaccination programs, especially as the WHO has given …
[HTML][HTML] Sensitization to alpha‐gal as a cause of idiopathic anaphylaxis
T Ranasinghe, IS Aberathna, J Jayamali… - Clinical and …, 2023 - ncbi.nlm.nih.gov
To the Editor, The incidence of anaphylaxis continues to rise globally based on hospital data
from Europe (Sweden), United States, Australia, Brazil and some Asian (Japan) countries. 1…
from Europe (Sweden), United States, Australia, Brazil and some Asian (Japan) countries. 1…